Company / Shares Outstanding
Outlook Therapeutics, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
23.9M
FY2025
5-year range
9.0M / 28.6M
FY2021-FY2025
Trend
-16.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has fluctuated over the past 6 years, ranging from 9027491.00 in FY2019 to 28609995.00 in FY2020.
Based on SEC 10-K filings.
23905635.00 in FY2025 with a 5-year CAGR of -3.5%.
Increased from 9027491.00 to 23905635.00 over the past 6 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -3.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shares outstanding decreased 16.4% year-over-year.
- Peak shares outstanding was recorded in FY2020.
- Lowest shares outstanding in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 23.9M | -16.4% |
| FY2020 | 28.6M | +216.9% |
| FY2019 | 9.0M | -63.8% |
| FY2018 | 24.9M | +9.3% |
| FY2017 | 22.8M | +141.6% |
| FY2016 | 9.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026